To distinguish the two groups, you really need to see the echocardiogram and the measurement of LVEF. "That doesn't preclude that these medications could have a longer-term benefit—maybe the ...

Please provide your email address to receive an email when new articles are posted on . Empagliflozin, an SGLT2 inhibitor, improved left ventricular function and quality of life in patients with HF ...

Approximately 20% had atrial fibrillation. Echocardiography showed that most patients had no LV regional wall motion abnormalities, with good global systolic function but evidence of LV hypertrophy.

For patients who have heart failure with reduced ejection fraction (HFrEF) and coronary artery disease, improvements in LV function after revascularization are linked to better long-term outcomes, an ...

We describe the case of a previously healthy adolescent female who presented with chest discomfort and near-syncope, accompanied by trifascicular block and hypotension. Her clinical condition rapidly ...

Please provide your email address to receive an email when new articles are posted on . Subclinical left ventricular abnormalities in SSc impact survival and increase dyspnea risk. LV ejection ...

Background Marathon running has numerous cardiovascular effects. Studies report transient physiological changes, while others ...

Cardiac physiologic pacing, also known as cardiac resynchronization therapy, is indicated in patients with heart failure, reduced left ventricular ejection fraction (LVEF) of 50% or less, and either a ...

Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...